Total Price: $0.00
Contact Information
Recombinant Human DR6/TNFRSF21 Protein (His Tag)
SKU: PKSH033441-50
To better serve you, we would like to discuss your specific requirement.
Please Contact Us for a quote.
Recombinant Human DR6/TNFRSF21 Protein (His Tag)
| SKU # | PKSH033441 |
| Expression Host | HEK293 Cells |
Description
| Synonyms | CD358, DR6, Death Receptor 6, TNFRSF21, Tumor Necrosis Factor Receptor Superfamily Member 21 |
| Species | Human |
| Expression Host | HEK293 Cells |
| Sequence | Gln42-Leu350 |
| Accession | O75509 |
| Calculated Molecular Weight | 34.6 kDa |
| Observed Molecular Weight | 58 kDa |
| Tag | C-His |
| Bio-activity | Not validated for activity |
Properties
| Purity | > 95 % as determined by reducing SDS-PAGE. |
| Endotoxin | < 1.0 EU per μg of the protein as determined by the LAL method. |
| Storage | Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months. |
| Shipping | This product is provided as lyophilized powder which is shipped with ice packs. |
| Formulation | Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. Normally 5% - 8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization. Please refer to the specific buffer information in the printed manual. |
| Reconstitution | Please refer to the printed manual for detailed information. |
Background
Tumor Necrosis Factor Receptor Superfamily Member 21 (TNFRSF21) is a type I transmembrane receptor that includes four extracellular cysteine-rich motifs and a cytoplasmic death domain. DR6 is highly expressed in heart; brain; placenta; pancreas; lymph node; thymus and prostate. DR6 may activate NF-kappa-B and JNK to promote apoptosis and T-cell differentiation. In addition; DR6 binds with N-APP; which is released by the deprivation of Trophic-factor. It triggers caspase activation and degeneration of both neuronal cell bodies (via caspase-3) and axons (via caspase-6). DR6 is also expressed on the tumor cell lines and can be induced by TNF-α.